Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access (R) GI Monitor assay on the UniCel (R) Dxl 800 Immunoassay System [PDF]
, 2008 Background: Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. Methods: The analytical and clinical performance of the Access(R) GI Monitor assay (Beckman Coulter) was evaluated on ...
Barone D +15 more
core +5 more sources
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses [PDF]
, 2011 Background: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy.
Burges, Alexander +9 more
core +1 more source
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors [PDF]
, 2009 Background: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT).
Burges, Alexander +8 more
core +1 more source
Higher Carbohydrate Antigen 125 Levels Are Associated with Increased Risk of Coronary Heart Disease in Elderly Chinese: A Population-Based Case-Control Study [PDF]
, 2013 Background: High carbohydrate antigen 125 (CA-125) level was reported to be associated with some cardiac dysfunctions, such as chronic heart failure, but the relationship between CA-125 level and coronary heart disease (CHD) risk remains unclear. The aim
He, Meian +11 more
core +3 more sources
Journal of Evidence-Based Integrative Medicine, 2023 Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD +5 more
doaj +1 more source
Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker [PDF]
, 2012 The relentless discovery of cancer biomarkers demands improved methods for their detection. In this work, we developed protein imprinted polymer on three-dimensional gold nanoelectrode ensemble (GNEE) to detect epithelial ovarian cancer antigen-125 (CA
Delerue-Matos, Cristina +3 more
core +1 more source
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. [PDF]
PLoS ONE, 2017 OBJECTIVES:Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features.
Sofi Isaksson +7 more
doaj +1 more source
Combining Multiple Serum Biomarkers in Tumor Diagnosis: A Clinical Assessment [PDF]
, 2013 The present study aimed to assess the diagnostic/ prognostic value of various clinical tumor markers, including carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), cytokeratin 19 (CYFRA21-1), α-fetoprotein (AFP), carbohydrate antigen-125 (CA ...
Chen, T +7 more
core +1 more source
CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding [PDF]
, 2018 Background: Incidence of endometrial cancer in India is increasing due to lifestyle changes and obesity. As 5 year survival rate of cancer confined to uterus is good, there is need for serum tumor marker for early diagnosis.
Habebullah, S +3 more
core +2 more sources
Frontiers in Cardiovascular Medicine, 2021 Background and Aims: Patients with light-chain cardiac amyloidosis (AL-CA) are characterized by high levels of serum carbohydrate antigen 125 (CA 125). However, studies have not explored the correlation between CA 125 and AL-CA. The aim of this study was
Muzheng Li +14 more
semanticscholar +1 more source